İçeriğe geç

Arthritis Consumer Experts & JointHealth™ Programs

@acejointhealth.bsky.social did:plc:ppp37mn2z5srv4cq6fouucqr

JointHealth™ — Your science-based source for easy-to-read arthritis info on treatments, research, and health policy. Visit us at www.jointhealth.org Follow us on Facebook: facebook.com/ACEJointHealth

Bluesky’a katılma tarihi:

Takipçi
140
Takip edilen
61
Post
293
Sıralamaya girdiği gün
0

Özet

Arthritis Consumer Experts & JointHealth™ Programs (@acejointhealth.bsky.social), 19 Kasım 2024 tarihinde katılan bir Bluesky kullanıcısı. 140 takipçisi var, 61 hesabı takip ediyor ve 293 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • ACR Journals@acr-journals.bsky.social

    Case-cohort study within ELSA-Brasil (N=585) investigated coronary artery calcium (CAC) prevalence in rheumatoid arthritis. RA was not associated with CAC prevalence or incidence, but was associated with greater CAC progression over a 4-year period Arthritis Care & Research doi.org/10.1002/acr....

    Postu göster
  • ACR Journals@acr-journals.bsky.social

    Can rheumatoid arthritis remission be predicted using routine baseline data? In 28,900 treatment courses across 11 registries, an externally validated machine learning model showed good rule-out performance but limited gain over logistic regression Arthritis & Rheumatology doi.org/10.1002/art....

    Postu göster
  • A Chronic Voice@achronicvoice.com

    "Sometimes I pushed myself to do [the #work ] anyway..just to keep the peace & wound up making myself sick or nearly passing out." (Realities of Trying to Maintain #Employment with a #Disability): buff.ly/PLvijUc by @2HeartCore4U.bsky.social #ChronicIllness #career #workplace #accommodations

    Postu göster
  • ACR Journals@acr-journals.bsky.social

    Among 66 patients with Still's disease receiving first-line IL-1 inhibitor therapy, IL-18 levels, particularly at 3 months after IL-1i initiation, could predict long-term disease activity, risk of MAS, & chronic-persistent disease trajectory Arthritis & Rheumatology doi.org/10.1002/art.... #Medsky

    Postu göster
  • ACR Journals@acr-journals.bsky.social

    Comparing effects of JAKi on endothelial cell dysfunction & apoptosis showed that despite JAKi protective effects, thrombotic risk factors triggered by TNF & IL-17A persist after treatment with most JAKi. Peficitinib & fedratinib inhibited endothelial cell viability doi.org/10.1002/acr2... #Medsky

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.

Bu hesap kimseyi bloklamıyor.